AmerisourceBergen Stock Forecast, Price & News

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AmerisourceBergen stock.
View analyst ratings for AmerisourceBergen or view top-rated stocks.

Wall Street analysts have given AmerisourceBergen a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AmerisourceBergen wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for AmerisourceBergen.

AmerisourceBergen Co. (NYSE:ABC) issued its earnings results on Tuesday, May, 4th. The company reported $2.53 EPS for the quarter, beating the Zacks' consensus estimate of $2.48 by $0.05. The business earned $49.15 billion during the quarter, compared to analyst estimates of $50.06 billion. AmerisourceBergen had a negative net margin of 1.91% and a positive trailing twelve-month return on equity of 277.60%. The company's quarterly revenue was up 3.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.40 EPS.
View AmerisourceBergen's earnings history.

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ABC shares have increased by 40.1% and is now trading at $119.03.
View which stocks have been most impacted by COVID-19.

AmerisourceBergen declared a quarterly dividend on Wednesday, May 5th. Investors of record on Monday, May 17th will be paid a dividend of $0.44 per share on Tuesday, June 1st. This represents a $1.76 annualized dividend and a dividend yield of 1.48%. The ex-dividend date is Friday, May 14th.
View AmerisourceBergen's dividend history.

AmerisourceBergen pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.48%. AmerisourceBergen does not yet have a strong track record of dividend growth. The dividend payout ratio of AmerisourceBergen is 22.28%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 17.64% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.
View AmerisourceBergen's dividend history.

AmerisourceBergen issued an update on its FY 2021 earnings guidance on Tuesday, June, 15th. The company provided EPS guidance of $8.900-9.100 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.540. The company issued revenue guidance of $210 B-, compared to the consensus revenue estimate of $204.74 billion.

10 equities research analysts have issued 12 month target prices for AmerisourceBergen's shares. Their forecasts range from $88.00 to $150.00. On average, they anticipate AmerisourceBergen's stock price to reach $123.78 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price.
View analysts' price targets for AmerisourceBergen or view top-rated stocks among Wall Street analysts.

447 employees have rated AmerisourceBergen CEO Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among AmerisourceBergen's employees.

Some companies that are related to AmerisourceBergen include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all of ABC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), The Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), The Home Depot (HD) and Pfizer (PFE).

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

AmerisourceBergen's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.95%), JPMorgan Chase & Co. (3.61%), Boston Partners (2.41%), FIL Ltd (1.41%), Geode Capital Management LLC (1.23%) and Burgundy Asset Management Ltd. (1.12%). Company insiders that own AmerisourceBergen stock include Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch and Steven H Collis.
View institutional ownership trends for AmerisourceBergen.

ABC stock was sold by a variety of institutional investors in the last quarter, including Amundi Asset Management US Inc., Glenmede Trust Co. NA, The PNC Financial Services Group Inc., Janus Henderson Group PLC, Lazard Asset Management LLC, Great West Life Assurance Co. Can, Retirement Systems of Alabama, and Northern Trust Corp. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Robert P Mauch, and Steven H Collis.
View insider buying and selling activity for AmerisourceBergen or view top insider-selling stocks.

ABC stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Glenview Capital Management LLC, Suvretta Capital Management LLC, Royal Bank of Canada, Boston Partners, Neuberger Berman Group LLC, Scout Investments Inc., and Pensioenfonds Rail & OV.
View insider buying and selling activity for AmerisourceBergen or or view top insider-buying stocks.

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ABC stock can currently be purchased for approximately $119.03.

AmerisourceBergen has a market capitalization of $24.45 billion and generates $189.89 billion in revenue each year. The company earns $-3,408,720,000.00 in net income (profit) each year or $7.90 on an earnings per share basis.

AmerisourceBergen employs 22,000 workers across the globe.

The following companies are subsidiares of AmerisourceBergen: ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group AG, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Oncology Network Solutions Inc., IntrinsiQ, Lash Group, MWI Veterinary Supply, MWI Veterinary Supply Co., MWI Veterinary Supply Inc., Network for Medical Communications & Research, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, World Courier, World Courier Group S.à r.l., and Xcenda.

AmerisourceBergen was founded in 2001.

The official website for AmerisourceBergen is www.amerisourcebergen.com.

AmerisourceBergen is headquartered at 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087.

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]